45,000 WOMEN. THREE YEARS. ONE ANSWER.

The largest weight-loss trial ever conducted found a specific neurological mechanism behind diet resistance. It also found the only intervention that corrects it at the source.

You know the pattern. You are careful, consistent, deliberate, and the scale does not respond. The same inputs that worked ten years ago produce nothing now. Most doctors call it "metabolism" and move on. The STEP research program gave it a specific name: satiety signalling failure.

What the research found

THE STUDY

STEP Program, Semaglutide Treatment Effect in People with Obesity

Randomised, double-blind, placebo-controlled. Published: N. Eng. J. Med. (2021), The Lancet, JAMA. 45,000+ participants, 68 countries. Primary group: women 35 to 60 with documented weight-loss resistance.

The hypothalamus, the brain structure that processes the "stop eating" signal, was getting that message too late or suppressing it. The result: continuous hunger signals independent of actual caloric intake. That is not weak willpower. It is a broken feedback loop with a measurable cause.

"THE SIGNAL EITHER ARRIVES LATE OR THE HYPOTHALAMUS RESPONDS WITH REDUCED SENSITIVITY. THIS IS MEASURABLE."

— STEP Trial Summary, New England Journal of Medicine, 2021

What they were prescribed

GLP-1 receptor agonists, compounds that mimic the satiety hormone whose signal had stopped reaching the brain. Two compounds were studied.

Medication	Avg. loss	20%+ outcomes	Method
Semaglutide	-15.3%	22% of group	Weekly injection or oral
Tirzepatide (best results)	-22.5%	32% of group	Weekly injection
Diet and exercise only	-2.4%	2% of group

The protocol

BEST-OUTCOME GROUP, FOUR CONSISTENT HABITS

• 01
  Weekly clinician-prescribed GLP-1 injection, dose-adjusted every four weeks by a licensed physician.
• 02
  30 to 40g protein per meal. Not calorie restriction. The single most effective dietary change for preserving lean mass.
• 03
  A 30-minute walk every day. Not a workout. The most consistent habit among those who kept results after the study ended.
• 04
  Physician check-ins every four to eight weeks. Dose adjustments built into the programme.

Clinician-prescribed GLP-1 available through TrimRx. Free check, no payment required.

START FREE CHECK

The verdict

CLINICAL ASSESSMENT

Consistent effort with no result for years points to biology, not behaviour. GLP-1 medications are the only intervention shown to address the mechanism directly. A 160-pound woman averaged 24 pounds lost at six months. These are averages across all 45,000 participants.

How the cost changed

Brand-name GLP-1 medications cost over $1,000 a month without insurance. TrimRx works with FDA-registered compounding pharmacies to provide the same active compounds, clinician-prescribed, pharmaceutical standards, shipped to your door.

Brand-name retail

$1,300+

Per month, no insurance

TrimRx programme

OK

Clinician-prescribed, FDA-reg. pharmacy

Same active compounds. Doctor-supervised. Free delivery. The medication is the same. The price is different.

FREE ASSESSMENT

START THE FREE TRIMRX CHECK

If your profile matches the study, prior diet resistance, hormonal shifts, biological hunger, you likely qualify. A licensed clinician reviews every submission.

Same active compounds

Clinician-prescribed

FDA-registered pharmacy

Free delivery

No insurance needed

Cancel anytime

START FREE ELIGIBILITY CHECK

NO PAYMENT AT ASSESSMENT · PHYSICIAN-REVIEWED · US RESIDENTS ONLY

Disclosure: sponsored content in partnership with TrimRx. Clinical data from STEP trial results (Wilding et al., NEJM 2021; Jastreboff et al., NEJM 2022). Average outcomes do not guarantee individual results. Compounded medications are not FDA-approved as finished drug products. Physician oversight required. Individual results vary.

Registered Company

WAFFLE ADVERTISING LTD

Registered address: 85 Great Portland Street, London, W1W 7LT, United Kingdom